Salesforce's $47.50/Share Bid for Braze Triggers Fairness Probe; Prior Bull Case Exceeded

What happened

Braze shares jumped on news that Salesforce agreed to acquire the company for $47.50 per share in cash, valuing Braze at approximately $5.66 billion enterprise value, far above its recent trading range of $21-$22. The acquisition follows a period in which Braze demonstrated improving profitability, with Q1 FY2027 revenue up 30.2% year over year and positive free cash flow, but the stock had been volatile and underappreciated by public markets. The announcement has drawn an investigation by Amparo Investor Rights into the fairness of the proposed price, a common but not always consequential step in M&A. From a fundamental perspective, the offer exceeds our prior bull-case implied value of $36 by roughly 32%, suggesting a generous premium for control or strategic value. The key question now is whether the deal will close as proposed, whether a higher bid emerges, or whether shareholders face any appraisal risk.

Implication

The $47.50 all-cash offer from Salesforce represents a 35% premium to our previous bull-case implied value of $36, indicating that the market may have been discounting the company's growth and profitability inflection, or that the acquirer sees strategic value beyond our fundamental model. Given the significant premium, the immediate risk for shareholders is deal failure or a drawn-out process, which could cause the stock to revert toward its pre-announcement level of around $21-22, while the upside from a higher bid is uncertain but possible given the ongoing investigation. The Amparo investigation is a routine step in such transactions and does not by itself indicate the price is inadequate, but it may pressure the companies to provide more disclosure on the sales process or fairness opinion. For investors who bought based on the prior 'Potential Buy' thesis, the acquisition effectively caps the upside at the offer price, so the rational decision is to either hold to collect the premium if the deal closes or sell into strength if there is uncertainty about completion. We would revise our rating from 'Potential Buy' to 'Hold for Deal Outcome,' as the standalone fundamental analysis is no longer the primary driver, and monitor regulatory, shareholder vote, and any competing bids.

Thesis delta

The investment thesis shifts from a fundamental turnaround/growth story to a merger arbitrage situation. The prior rating of 'Potential Buy' with a trim above $32 is superseded by the $47.50 acquisition offer, which exceeds our bull case and implies the market or acquirer assigns higher value than our model. We now assess Braze based on the probability of deal completion and the possibility of a superior proposal, rather than standalone operating performance.